Financial Performance - The company incurred a loss from operations of $32.4 million and $26.9 million for the years ended December 31, 2025 and 2024, respectively, with an accumulated deficit of $480.8 million as of December 31, 2025[90]. - Negative cash flow from operating activities was $27.6 million and $22.6 million for the years ended December 31, 2025 and 2024, respectively, with expectations of continued negative cash flow in the foreseeable future[95]. - The company expects to incur significant losses for the foreseeable future due to ongoing costs and expenses related to product development and commercialization efforts[91]. - The company anticipates incurring substantial research and development costs to develop and commercialize its AI/ML Foundational Technology and other products, with no guarantee of achieving profitability or significant licensing revenue[153]. - The company expects its financial results to vary significantly due to fluctuations in operating costs and product demand, making quarter-to-quarter comparisons less meaningful[171]. Market and Competitive Environment - The company operates in a competitive industry with rapid technological changes, and its products may not remain competitive against alternatives[120]. - The company is targeting large businesses, including U.S. government prime contractors, which have significant negotiating power and may develop competitive internal solutions[117]. - The company faces challenges in attracting and retaining customers, which may adversely affect revenue growth and financial condition[109]. - The company recognizes that competitors may respond more quickly to emerging technologies and may have greater resources, impacting its ability to attract customers[129]. - The company has limited experience in commercializing its products, which may hinder its ability to effectively bring products to market[96]. Product Development and Sales Cycle - The sales cycle for the company's Palladyne IQ product is estimated to be between 12 and 18 months, while the sales cycles for other products remain unknown, potentially leading to longer customer testing periods[104]. - The company is in the early stages of commercialization for several products, including Palladyne IQ and SwarmOS, and may face delays in product development and market introduction[132]. - The company has no commercial customers for its AI/ML Foundational Technology related products as of the report date, which may impair its ability to generate material revenues[103]. Legal and Compliance Risks - The company may incur significant legal defense costs and reputational damage from product liability claims, regardless of their merit[142]. - The company may face claims related to noncompliance with open source license terms, which could result in costly litigation or require significant re-engineering of software[146]. - Compliance with the Sarbanes-Oxley Act and other regulations has resulted in substantial legal and financial compliance costs, straining personnel and resources[179]. - The company is subject to anti-corruption and anti-money laundering laws, with violations potentially resulting in severe consequences for business operations and financial results[214]. - The introduction of AI/ML technologies may lead to increased regulatory scrutiny and compliance costs, impacting the company's operations and reputation[191]. Supply Chain and Operational Risks - As of December 31, 2025, most key suppliers are based in the United States, with some components sourced from sole or single source suppliers, which poses risks to the supply chain and could adversely affect sales and profitability[155]. - The company faces risks associated with product flaws, which could lead to lower return on investment for customers and significant safety concerns, potentially impacting financial results and reputation[137]. - The company faces challenges in negotiating favorable pricing and terms with suppliers, which may impact production costs and availability of components[156]. Human Resources and Management - Retaining key personnel is critical for the company's success, and the loss of senior management could adversely affect product development and commercialization efforts[172]. - The company faces intense competition for skilled AI/ML software engineers, which may hinder its ability to attract and retain qualified personnel[175]. - The management team has broad discretion in making strategic decisions, which may not always lead to desired outcomes, potentially affecting growth prospects and stock price[150]. Financial Structure and Shareholder Impact - The issuance of additional shares of Common Stock could depress trading prices and dilute existing stockholders' interests[237]. - The company's stock price may decline due to large numbers of shares being subject to employee equity awards, leading to concentrated selling periods[238]. - The exercise of deSPAC Warrants and 2024 Warrants would increase the number of shares eligible for future resale in the public market, resulting in dilution to existing stockholders[251][253]. Cybersecurity and Data Privacy - The company faces cybersecurity risks from operational systems and third-party vendors, which could disrupt operations and compromise sensitive data[207]. - Compliance with evolving data privacy and security laws may necessitate changes to business practices, potentially affecting growth strategies and customer acquisition[205]. - Any security breaches or system outages could lead to significant legal and financial exposure, damaging the company's reputation and customer relationships[212]. Strategic Relationships and Growth Opportunities - Strategic business relationships are deemed crucial for growth, but the company may struggle to identify or secure suitable opportunities in the future[188]. - The company completed acquisitions of GuideTech, Warnke Precision Machining, and MKR Fabricators, which may present integration risks and uncertainties[134]. - Acquisitions may require significant management attention and could divert resources from existing operations, potentially affecting financial results[189].
Sarcos Technology and Robotics (STRC) - 2025 Q4 - Annual Report